Deutsche Bank
XFOR icon

Deutsche Bank’s X4 Pharmaceuticals XFOR Stock Holding History

Deutsche Bank’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Buy
+78,885
New +$324K ﹤0.01% 2936
2025
Q2 		– Sell
-8,921
Closed -$64.2K – 3757
2025
Q1 		$64.2K Hold
8,921
– – ﹤0.01% 3322
2024
Q4 		$195K Buy
8,921
+7,568
+559% +$121K ﹤0.01% 3101
2024
Q3 		$27.2K Hold
1,353
– – ﹤0.01% 3450
2024
Q2 		$23.5K Sell
1,353
-407
-23% -$13.3K ﹤0.01% 3417
2024
Q1 		$73.4K Buy
+1,760
New +$49K ﹤0.01% 3284
2023
Q4 		– Sell
-2,041
Closed -$66.7K – 3713
2023
Q3 		$66.7K Hold
2,041
– – ﹤0.01% 3336
2023
Q2 		$119K Buy
+2,041
New +$105K ﹤0.01% 3194
2021
Q2 		– Sell
-348
Closed -$90K – 4825
2021
Q1 		$90K Sell
348
-32
-8% -$8.41K ﹤0.01% 4034
2020
Q4 		$73K Buy
380
+108
+40% +$21.2K ﹤0.01% 4004
2020
Q3 		$55K Buy
272
+19
+8% +$4.55K ﹤0.01% 3844
2020
Q2 		$71K Buy
253
+67
+36% +$18.3K ﹤0.01% 3634
2020
Q1 		$56K Sell
186
-62
-25% -$17.6K ﹤0.01% 3491
2019
Q4 		$78K Buy
248
+120
+94% +$43K ﹤0.01% 3705
2019
Q3 		$47K Sell
128
-48
-27% -$19K ﹤0.01% 3968
2019
Q2 		$78K Buy
176
+41
+30% +$20.8K ﹤0.01% 4330
2019
Q1 		$69K Buy
135
+99
+275% +$54.6K ﹤0.01% 4454
2018
Q4 		$14K Sell
36
-30
-45% -$11.4K ﹤0.01% 4822
2018
Q3 		$19K Buy
66
+17
+35% +$7.21K ﹤0.01% 4949
2018
Q2 		$32K Buy
49
+11
+29% +$36K ﹤0.01% 4901
2018
Q1 		$155K Buy
+38
New +$111K ﹤0.01% 4316

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank's XFOR Position: Q2 2026 in Review

Deutsche Bank opened a new position in X4 Pharmaceuticals (XFOR) in Q2 2026: 78,885 shares worth $368K. The stake represents ﹤0.01% of the portfolio and ranks #2936 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in XFOR as recently as Q1 2025.

Deutsche Bank first reported a position in XFOR in Q1 2018 and has held it in 21 quarters since. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Deutsche Bank held 78,885 shares of X4 Pharmaceuticals worth $368K as of Q2 2026.
  • X4 Pharmaceuticals was a new Deutsche Bank position in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2936 holding.
  • Deutsche Bank first reported a position in X4 Pharmaceuticals in Q1 2018 and has held it in 21 quarters since.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.